Financial Advisory Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $787K | Sell |
4,322
-26
| -0.6% | -$4.48K | 0.14% | 50 |
|
|
2023
Q4 | $674K | Buy |
4,348
+100
| +2% | +$14.6K | 0.13% | 54 |
|
|
2023
Q3 | $633K | Hold |
4,248
| – | – | 0.13% | 54 |
|
|
2023
Q2 | $572K | Hold |
4,248
| – | – | 0.11% | 54 |
|
|
2023
Q1 | $677K | Hold |
4,248
| – | – | 0.14% | 52 |
|
|
2022
Q4 | $687K | Sell |
4,248
-138
| -3% | -$21.2K | 0.15% | 51 |
|
|
2022
Q3 | $589K | Hold |
4,386
| – | – | 0.13% | 52 |
|
|
2022
Q2 | $672K | Hold |
4,386
| – | – | 0.14% | 51 |
|
|
2022
Q1 | $711K | Buy |
4,386
+63
| +1% | +$9.15K | 0.14% | 51 |
|
|
2021
Q4 | $585K | Buy |
4,323
+173
| +4% | +$20.4K | 0.12% | 53 |
|
|
2021
Q3 | $448K | Hold |
4,150
| – | – | 0.1% | 56 |
|
|
2021
Q2 | $467K | Hold |
4,150
| – | – | 0.11% | 53 |
|
|
2021
Q1 | $449K | Hold |
4,150
| – | – | 0.11% | 53 |
|
|
2020
Q4 | $445K | Hold |
4,150
| – | – | 0.12% | 53 |
|
|
2020
Q3 | $363K | Sell |
4,150
-40
| -1% | -$3.77K | 0.12% | 52 |
|
|
2020
Q2 | $411K | Buy |
4,190
+140
| +3% | +$12.3K | 0.14% | 48 |
|
|
2020
Q1 | $309K | Sell |
4,050
-75
| -2% | -$6.39K | 0.1% | 50 |
|
|
2019
Q4 | $365K | Hold |
4,125
| – | – | 0.1% | 56 |
|
|
2019
Q3 | $312K | Sell |
4,125
-600
| -13% | -$41.1K | 0.09% | 57 |
|
|
2019
Q2 | $323K | Buy |
4,725
+625
| +15% | +$49.1K | 0.09% | 58 |
|
|
2019
Q1 | $330K | Buy |
4,100
+100
| +3% | +$8.18K | 0.09% | 54 |
|
|
2018
Q4 | $369K | Hold |
4,000
| – | – | 0.11% | 50 |
|
|
2018
Q3 | $378K | Hold |
4,000
| – | – | 0.1% | 47 |
|
|
2018
Q2 | $371K | Buy |
4,000
+300
| +8% | +$29.3K | 0.1% | 49 |
|
|
2018
Q1 | $350K | Buy |
3,700
+100
| +3% | +$11K | 0.11% | 48 |
|
|
2017
Q4 | $348K | Buy |
3,600
+200
| +6% | +$18.8K | 0.1% | 50 |
|
|
2017
Q3 | $302K | Sell |
3,400
-100
| -3% | -$7.61K | 0.1% | 52 |
|
|
2017
Q2 | $254K | Buy |
3,500
+200
| +6% | +$13.4K | 0.09% | 58 |
|
|
2017
Q1 | $215K | Sell |
3,300
-350
| -10% | -$22K | 0.07% | 58 |
|
|
2016
Q4 | $229K | Buy |
3,650
+150
| +4% | +$9.16K | 0.09% | 57 |
|
|
2016
Q3 | $221K | Hold |
3,500
| – | – | 0.09% | 55 |
|
|
2016
Q2 | $217K | Buy |
+3,500
| New | +$213K | 0.11% | 52 |
|
|
2016
Q1 | – | Sell |
-3,850
| Closed | -$228K | – | 60 |
|
|
2015
Q4 | $228K | Buy |
+3,850
| New | +$222K | 0.11% | 50 |
|
Other funds holding ABBV
Financial Advisory Group's ABBV Position: Q1 2024 in Review
Financial Advisory Group reduced its AbbVie (ABBV) stake by 0.6% in Q1 2024, selling an estimated $4.48K and leaving 4,322 shares worth $787K. The position accounts for 0.14% of the portfolio, ranked #50.
Financial Advisory Group first reported a position in ABBV in Q4 2015 and has held it in 33 quarters since. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.
- Financial Advisory Group held 4,322 shares of AbbVie worth $787K as of Q1 2024.
- Financial Advisory Group sold 26 AbbVie shares in Q1 2024, an estimated $4.48K.
- AbbVie made up 0.14% of Financial Advisory Group's portfolio in Q1 2024, its #50 holding.
- Financial Advisory Group first reported a position in AbbVie in Q4 2015 and has held it in 33 quarters since.
- 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.
Based on Financial Advisory Group's 13F filing for Q1 2024, filed 10 May 2024.